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Abstract
Motivation: In biology, we are often faced with multiple datasets recorded on the same set of
objects, such as multi-omics and phenotypic data of the same tumors. These datasets are typically
not independent from each other. For example, methylation may influence gene expression, which
may, in turn, influence drug response. Such relationships can strongly affect analyses performed
on the data, as we have previously shown for the identification of biomarkers of drug response.
Therefore, it is important to be able to chart the relationships between datasets.
Results: We present iTOP, a methodology to infer a topology of relationships between datasets.
We base this methodology on the RV coefficient, a measure of matrix correlation, which can be
used to determine how much information is shared between two datasets. We extended the RV co-
efficient for partial matrix correlations, which allows the use of graph reconstruction algorithms,
such as the PC algorithm, to infer the topologies. In addition, since multi-omics data often contain
binary data (e.g. mutations), we also extended the RV coefficient for binary data. Applying iTOP to
pharmacogenomics data, we found that gene expression acts as a mediator between most other
datasets and drug response: only proteomics clearly shares information with drug response that is
not present in gene expression. Based on this result, we used TANDEM, a method for drug re-
sponse prediction, to identify which variables predictive of drug response were distinct to either
gene expression or proteomics.
Availability and implementation: An implementation of our methodology is available in the R
package iTOP on CRAN. Additionally, an R Markdown document with code to reproduce all figures
is provided as Supplementary Material.
Contact: a.k.smilde@uva.nl or l.wessels@nki.nl
Supplementary information: Supplementary data are available at Bioinformatics online.
1 Introduction
Rapid developments in high throughput measurement techniques to-
gether with rapid reduction in profiling costs have, for many bio-
logical problems, endowed us with multiple molecular datasets
recorded on the same set of objects. For example, pharmacogenom-
ics data contain, in addition to cancer type and drug response, vari-
ous omics datasets (mutation, copy number aberration (CNA),
methylation, gene expression and proteomics) recorded on the same
set of tumor cell lines (Iorio et al. 2016; Li et al. 2017). While this
provides an unprecedented view on the underlying biological prob-
lem, it also comes with some unique challenges. Specifically, the
recorded datasets are not independent of each other, but are
characterized by specific relationships. For example, copy number
alterations and methylation changes may influence gene expression,
which may, in turn, influence drug response. As we have demon-
strated earlier (Aben et al. 2016), these relationships can have pro-
found effects on further integrative analyses, especially biomarker
discovery. It is therefore imperative to obtain a full quantitative
characterization of these relationships, such as the illustrative top-
ology of relationships between datasets depicted in Figure 1A.
Here, we set out to characterize the relationships between data-
sets in terms of the amount of information that is shared between a
pair of datasets, and, more importantly, how this shared informa-
tion manifests itself in the relationship of a pair of datasets to a third
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dataset. For example, suppose we have two datasets, X1 and X2.
Suppose we can characterize the amount of shared information be-
tween X1 and X2 by a number between 0 and 1, with 0 being no
shared information and 1 representing maximal overlap in informa-
tion (Fig. 1B). This characterization of pairwise relationships can be
informative as such, as it can reveal whether, for example, there is
any shared information between gene expression and mutation data.
If we now introduce a third dataset, X3, we can also quantify the
amount of information shared between X1 and X3 and X2 and X3.
Assuming that these relationships are non-zero, we obtain the graph
in Figure 1C. Now it becomes particularly interesting to know
whether the shared information between X1 and X3 depends on X2.
Specifically, is the shared information between X1 and X3 contained
in the information in X2? In other words, does X2 mediate the effect
between X1 and X3? When these questions can be answered for all
datasets at hand, it reveals the minimal graph that represents the
conditional relationships between all datasets. As the number of
datasets grows, such a graph not only gives a very concise overview
of the relationships, but it is also an important guide in structuring
the analyses aimed at finding biomarkers of a given phenotype.
More specifically, suppose that X1, X2 and X3 represent mutation,
gene expression and drug response data for a cell line panel, and
that our goal is to extract molecular biomarkers of drug response.
Assume that, from our analyses, it emerged that all the information
shared between mutation (X1) and drug response (X3) is contained
in the gene expression data (X2) (Fig. 1D). This implies that we only
need to employ gene expression data to find biomarkers of drug
response.
To infer dataset topologies, we draw upon the approaches
employed to infer topologies between single variables (instead of
matrices). Specifically, for our earlier example, we can employ par-
tial correlation, e.g. cor x1; x3jx2ð Þ, to quantify the amount of infor-
mation that is shared between two variables (x1 and x3) that is not
present in the other variable (x2). If the effect of x1 on x3 is (almost
fully) mediated through x2, it follows that cor x1; x3jx2ð Þ  0, which
implies that we can remove the direct link between x1 and x3
(Fig. 1E). Graph reconstruction algorithms, such as the PC algo-
rithm (Colombo and Maathuis 2014; Peter et al. 2000), use this
property to infer the topology between multiple variables.
Here, we propose iTOP, a methodology for inferring topologies
between datasets. As with topology inference for single variables,
this methodology consists of two components: (i) a measure of (con-
ditional) similarity between datasets and (ii) the PC algorithm that
employs the (conditional) similarity measure to perform structure
learning, i.e. to infer the topology. As similarity measure we employ
the RV coefficient (Robert and Escoufier 1976), a measure of matrix
correlation. The basic idea of the RV coefficient is that datasets are
correlated when they have a similar configuration (e.g. similar clus-
tering) of the objects. We extend the RV coefficient to be applicable
to binary data by using Jaccard similarity to determine the configur-
ation of objects. This allows us to measure the shared information
between any of the molecular datasets, including intrinsically binary
datasets such as mutation data. In addition, to measure conditional
matrix similarity, we extend the RV coefficient for partial matrix
correlations. This allows us to quantify the amount of information
that is shared between two datasets (matrices), but not present in the
other dataset, analogous to single variables.
We employ iTOP, i.e. partial matrix correlation in conjunction
with the PC algorithm, to infer a topology of relationships between
datasets. First, we will demonstrate the RV coefficient with both
extensions (i.e. for partial matrix correlations and for binary data)
on artificial data. Subsequently, we will use this to infer the topology
of relationships between the pharmacogenomics datasets. We show
that gene expression acts as a mediator between most other datasets
and the drug response, and that only proteomics clearly shares infor-




Fig. 1. High-level overview of this work. (A) The goal of this work is to infer a topology of relationships between pharmacogenomics datasets (an example top-
ology is illustrated here). (B) When two datasets share information (i.e. when their RV coefficient is non-zero), we will indicate them as connected in a topology.
(C) A topology of three datasets that all share information. We will convert this topology to the one depicted in (D) if the shared information between X1 and X3 is
fully contained in X2. (E) To create these topologies we will draw on methods for inferring a topology between single variables using partial correlations. Top: the
original causality graph. Middle: the topology as inferred using correlations. Bottom: the inferred topology using partial correlations









roningen user on 07 January 2019
Based on this result, we will employ TANDEM, a method for drug
response prediction from multiple datasets (Aben et al. 2016), to
identify markers predictive of drug response that are distinct for pro-
teomics and gene expression.
2 Materials and methods
2.1 Matrix correlation using the RV coefficient
For dataset i, consider Xi the n  pi data matrix with objects in the
rows and variables in the columns. Here, we assume Xi to be
column-centered (of note, there is no need to scale the columns of
Xi). We define the corresponding nn configuration matrix Si as
follows:
Si ¼ XiXTi
Now consider a second dataset j, whose data matrix Xj has the
same objects on the same rows as Xi, but has a different set of varia-
bles. Hence, Xj is of size n  pj. Analogous to Xi, we will define a
configuration matrix Sj for Xj.
Sj ¼ XjXTj
Using the configuration matrices Si and Sj, we can then determine
the matrix correlation between these matrices using the RV
coefficient:
RV Si; Sj
  ¼ vec Sið ÞTvec Sj
 
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ




Where vec Sð Þ is the n2  1 vector in which the columns of S are
stacked on top of each other. When Xi and Xj are column-centered,
then mean vec Sið Þð Þ ¼ 0 and mean vec Sj
   ¼ 0, which means we
can interpret the above as a Pearson correlation coefficient.
RV Si; Sj
  ¼ cor vec Sið Þ; vec Sj  
2.2 The modified RV coefficient
For data matrices X where the number of variables is much greater
than the number of objects (i.e. P n), the RV coefficient is
known to be biased upwards (Mayer et al. 2011; Smilde et al.
2009). To account for this bias, we subtract the diagonal from the
configuration matrix, as in the modified RV coefficient (Smilde
et al. 2009).
~S i ¼ Si  diag Sið Þ
~S j ¼ Sj  diag Sj
 
















For a more complete discussion of the modified RV coefficient,
as well as our rationale for not using the adjusted RV coefficient
(Mayer et al. 2011) instead, we refer to the Supplementary
Material.
2.3 Partial matrix correlations
We extend the above matrix correlation formulation to partial ma-
trix correlations. Consider a third dataset, the n  pk matrix Xk,
that will be processed as above.
Sk ¼ XkXTk
~Sk ¼ Sk  diag Skð Þ
We can then compute the partial matrix correlation between
dataset i and j, corrected for dataset k, as
RV ~S i; ~S jj~Sk
 
¼ cor vec ~S i
 




Of note, the concept of partial matrix correlations has been
explored previously by Smouse et al. (1986), who based their meas-
ure on the Mantel Test (Nathan 1967). For a discussion of the
Mantel Test and why we prefer to base our measure of partial ma-
trix correlation on the RV coefficient, we refer to the Supplementary
Material.
2.4 Statistical inference for partial matrix correlations
We provide two methods for statistical inference for partial
matrix correlations: significance estimates and confidence inter-
vals. We note that these cannot be determined analytically (e.g.
using Fisher Transformation, which is commonly used to derive a
P-value for Pearson correlations), as the entries in vec Sð Þ are not
i.i.d.: multiple entries in vec Sð Þ correspond to the same object in S.
Instead, we will discuss a permutation test for significance esti-
mates and a bootstrapping procedure for calculating confidence
intervals.
We used a permutation test to assess significance of a (partial)
matrix correlation. In every permutation, the objects of every data-
set were independently shuffled and the (partial) matrix correlation
was computed on the shuffled data. Subsequently, the observed
(partial) matrix correlation was compared to the permuted values,









; for RVobs < 0
8>><
>>:
Where 1A is the indicator function that equals 1 when A is true,
RVobs is the observed (partial) matrix correlation, RVi the permu-
tated (partial) matrix correlation from the ith permutation and
nperm the number of permutations. Throughout the manuscript, we
used nperm ¼ 1000.
We used a percentile bootstrap procedure to calculate confidence
intervals. In each bootstrap, objects were obtained by drawing com-
plete cases randomly (with replacement) from the dataset, after
which the (partial) matrix correlation was calculated as defined
above. The 99% percentile interval of the obtained (partial) matrix
correlations was then used as a confidence interval. Throughout the
manuscript, we used 1000 bootstraps to determine a confidence
interval.
We note that row-wise permutation of the data matrices
(X ind;½ , with ind the indices of the objects after permutation) is
equivalent to permutation of both the rows and the columns of the
configuration matrices (S ind; ind½ ). Using this property, we decided
to permute the configuration matrices, as this prevents having to cal-
culate the configuration matrix in each permutation and hence
greatly speeds up the calculations. A similar approach was used for
bootstrapping.
2.5 Binary similarity measures
An advantage of converting the data matrices X to configuration
matrices S is that it allows us to use different similarity measures
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for different data types. For example, for continuous data,
we use:
S ¼ XXT
Note that each entry of S corresponds to an inner product be-
tween different objects in X, i.e.
S ¼ XXT ¼
xT1 x1 x
T
1 x2    xT1 xn
xT2 x1 x
T













Where xi is the i’th row in X and n is the number of rows in X.
We will refer to this similarity measure as ‘inner product similarity’.
2.5.1 Jaccard similarity
For binary data, we use Jaccard similarity. Jaccard similarity is
defined as the ratio of the number of elements where these vectors
have ones in common and the total number of positions where ones
occur in any of these two vectors. Consider the following contin-
gency table.
Where a is the number of elements where x¼0 and y¼0, b is
the number of elements where x¼1 and y¼0, etc. The Jaccard
Similarity can then be written as:
Jaccard x; yð Þ ¼ d
bþ cþ d
When all x¼0 and all y¼0, then b¼ c ¼ d¼0, which would re-
sult in Jaccard x; yð Þ¼0=0. In these cases, we define the Jaccard simi-
larity as Jaccard(x, y) ¼ 0.
Note that the Jaccard similarity is based on the number of posi-
tive matches (d) and not at all on the number of negative matches
(a). This is in line with our intuition of similarity in the binary data
at hand (mutation, CNA and cancer type). For example, when two
objects share the same mutations, we think this should contribute
more to their similarity than the number of mutations that both
objects lack.
We define configuration matrices using the Jaccard similarity in
the following way:
S ¼ Jaccard config Xð Þ
¼
Jaccard x1;x1ð Þ Jaccard x1; x2ð Þ    Jaccard x1; xnð Þ












We used kernel centering to center the configuration matrix S rather
than the underlying data matrix X. Essentially, kernel centering is
double centering (i.e. column- and row-wise centering) of the config-
uration matrix S (or in other words: the kernel), which we will show
to be equal to first column-centering the data matrix X and then
computing S ¼ XXT . Consider X the original data matrix and X the
column-centered data matrix. Likewise, consider S the original con-
figuration matrix and S the centered configuration matrix. Finally,
consider m the column-wise means of X and n the number of rows
in X. We will first consider an example using inner products as a
similarity measure.
S ¼ XXT
S ¼ X XT



























Interestingly, the final term expresses the kernel centered S in
terms of the non-centered S. This allows us to center configuration
matrices that are not based on inner-product similarity, such as
S ¼ Jaccard config Xð Þ. Column-centering X (the input space) makes
no sense here, as the resulting matrix would not consist of 0 s and 1 s
anymore and hence Jaccard config X
 
is not defined. However, we
can use kernel centering here to center the so-called kernel space cor-
responding to S.
S ¼ Jaccard config Xð Þ










The mutation, copy number aberration (CNA), methylation, cancer
type, gene expression and drug response data were sourced from
GDSC1000 (Iorio et al. 2016), and the proteomics data were
sourced from MCLP (Li et al. 2017) (Table 1). For the mutation and
CNA data, we used the reduced set of Cancer Functional Events
(CFEs) (Iorio et al. 2016), resulting in 300 and 425 binary variables,
respectively. For the methylation data, we used the CpG-island sum-
marized data, resulting in 14 426 continuous variables. For the can-
cer type data, we used the classification into 30 TCGA cancer types
or ‘OTHER’, resulting in 31 binary variables (Iorio et al. 2016). For
gene expression data, we used the gene level summarized data,
resulting in 17 419 continuous variables. The proteomics data con-
sist of 452 variables, of which 108 represent phospho-protein levels
and the remaining 344 represent protein abundance levels. For the
drug response data, we used the IC50-values (concentration at
which half of the cells are killed) for all 265 drugs.
Table 1. Overview of the pharmacogenomics datasets used in this
manuscript
Dimensionality Source Type Missing
values
Mutation 300 GDSC1000 Binary No
CNA 425 GDSC1000 Binary No
Methylation 14 429 GDSC1000 Continuous No
Cancer type 31 GDSC1000 Binary No
Gene expression 17 419 GDSC1000 Continuous No
Proteomics 452 MCLP Continuous Yes
Drug response 265 GDSC1000 Continuous Yes
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Of the 282 cell lines that were profiled in both GDSC1000 and
MCLP, 266 cell lines were characterized across all seven datasets.
This number was further reduced due to missing values in the pro-
teomics and drugs response data. For the proteomics data, after
removing all variables with >30% missing values, we retained 186
variables. Subsequently, after removing all objects with >30%
missing values, we retained 221 objects. We then intersected all
datasets with these 221 objects and applied the same two steps to
the drug response data, where we retained 206 objects and 217 vari-
ables. These 206 objects cover 27 of the 31 cancer types in the
GDSC1000 data. The remaining missing values (1% for the proteo-
mics and 5% for the drug response) were imputed using SVD im-
putation (Troyanskaya et al. 2001) as implemented in the
R package bcv.
3 Results
3.1 The RV coefficient
To illustrate the RV coefficient, consider the following example.
Figure 2A represents data matrix X1, a dataset with two variables
and 100 objects, where the first 50 objects form the green cluster
and the second 50 objects form the purple cluster. The second data
matrix, X2 (Fig. 2B), also consists of two variables and the same 100
objects with the same clustering as in X1. The third data matrix, X3
(Fig. 2C), is again a dataset with two variables and the same objects
as before, but now without any apparent clustering.
When converting these data matrices to configuration matrices
(similarity matrices), which indicate the configuration of the differ-
ent objects with respect to each other, it can be readily observed that
X1 and X2 contain the same information in terms of clustering
(Fig. 2D and E). Indeed, when computing the RV coefficient be-
tween X1 and X2 (by computing the Pearson correlation of the vec-
torized forms of the corresponding configuration matrices, see
Section 2), we obtain an RV coefficient close to one, indicating a
strong relationship. Conversely, when computing the RV coefficient
between X2 and X3, where the latter contains no clustering informa-
tion, we see that the configuration matrices are very different and R
V X2;X3ð Þ  0 (Fig. 2C and F).
3.2 Extending the RV coefficient for partial matrix
correlations
We illustrate partial matrix correlations using the following ex-
ample. Consider three datasets: X1, X2 and X3. Let X1 affect X2,
and let X2 affect X3 (Fig. 3). Observe that, consistent with the pro-
posed causality, X1 is most similar to X2 (only the purple cluster in
the bottom-left has been moved) and X3 is most similar to X2 (only
the blue cluster in the bottom-right has been moved). This of course
means that RV X1;X2ð Þ and RV X2;X3ð Þ will be non-zero.
However, note that also RV X1;X3ð Þ will be non-zero, as X1 and X3
do share information: the top three clusters have the same configur-
ation in both datasets. Therefore, if we were to infer a topology
based on the matrix correlations, we cannot rule out a direct link
from X1 to X3.
A B C
D E F
Fig. 2. The RV coefficient explained using three simple example datasets. The data matrices X1, X2 and X3 (represented in A-C) are converted to configuration
matrices S1, S2 and S3, respectively (D–F). Using the configuration matrices, it can be readily seen that RV ðX1;X2Þ  1 and RV ðX2;X3Þ  0
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Using the partial matrix correlation RV X1;X3jX2ð Þ, we can
rule out a direct link from X1 to X3. As X2 has the same configur-
ation in the top three clusters, correcting for X2 results in
RV X1;X3jX2ð Þ ¼ 0:005, which is not significantly different from
zero (P-value: 0.354, 99% confidence interval: 0.27 to 0.28).
Therefore, using partial matrix correlations, we can indeed recon-
struct the original topology.
3.3 Extending the RV coefficient for binary data
The RV coefficient has been proposed for comparing data matrices
containing continuous values. Specifically, in the original formula-
tion of the RV coefficient, the configuration matrices are determined
using the inner product between objects (Section 2), which is tail-
ored to comparing continuous values. To determine (partial) matrix
correlations for datasets containing binary values, we propose to
create the configuration matrices using Jaccard similarity, which
determines similarity between binary variables (Section 2). We
assessed the performance of this approach using a simulation study.
First, to establish a reference, we performed a simulation study
in which two continuous valued matrices were compared. In this
simulation, the values in X1 and X2 were randomly drawn from
N(10, 1) and N(0, 1), respectively, where N(l,r) represents a
Gaussian distribution with mean l and standard deviation r.
Subsequently, we defined a third matrix as X3 ¼ (1 – a)X1 þ aX2.
We compared RV X1;X3ð Þ for different values of a, and both with
and without column-wise centering of the data matrices (Fig. 4A).
Regardless of centering, we found that RV X1;X3ð Þ ¼ 1 for a ¼ 0
and RV X1;X3ð Þ  0 for a ¼ 1, as expected. For intermediate values
of a however, we see big differences between the approach using
centering and the one without centering. Without centering, RV
X1;X3ð Þ remains very close to 1 for values of a approaching 1,
which is counterintuitive. With centering, RV X1;X3ð Þ slowly
decreases to 0 as a increases, which is according to expectation.
These differences can be attributed to the fact that inner product dis-
tance is dependent on the relative position of the objects with respect
to the origin: in the uncentered case, for a	0.9, the vectors repre-
senting the objects in X1 and X3 will be highly collinear, resulting in
an RV coefficient close to one (Supplementary Fig. S1). This experi-
ment emphasizes the importance of centering the data prior to
applying the RV coefficient.
We then performed a simulation in which two binary valued
matrices were compared. Values in X1 were randomly drawn from
Binom(0.5) (Binomial distribution with P¼0.5). X2 was set equal
to X1, but with a the fraction of binary values that were flipped. We
varied a only up to 0.5, as this is the point at which the configur-
ation of objects in X1 and X2 is maximally apart (at a ¼ 1, X1 and
X2 are simply inverted and, given that the RV coefficient is rotation
independent, the resulting RV coefficient will be 1 again). Again RV
X1;X2ð Þ was compared for different values of a and both with and
without centering (Fig. 4B). As binary data cannot be column cen-
tered (it would not be binary anymore after centering), we instead
used kernel centering to center the configuration matrix obtained
using the Jaccard similarity (Section 2). For a ¼ 0, RV X1;X2ð Þ ¼ 1,
both with and without centering, as the two matrices are exactly the
same. However, for a in (0, 50], RV X1;X2ð Þ remained very close to
1 in the uncentered case, while it slowly decreased to 0 in the cen-
tered case. Hence, as at a ¼ 0.5 the configuration of X1 and X2 is
maximally apart, the centered case is preferable.
Using these simulation experiments, we have shown that the
Jaccard similarity can be used to construct configuration matrices
for binary data. Additionally, we have shown the importance of cen-
tering and that kernel centering can be used for the binary case.
3.4 Application to pharmacogenomics data
We applied the RV coefficient with both extensions to a collection
of pharmacogenomics data (a combination of GDSC1000 (Iorio
et al. 2016) and MCLP (Li et al. 2017), see Section 2) to infer how
the different datasets in this collection are related to each other. This
collection consists of three binary datasets (mutation, CNA and can-
cer type) and four continuous datasets (methylation, gene expres-
sion, proteomics and drug response). Intersecting the objects that
are present in all datasets resulted in data for 206 objects.
We used the PC algorithm (Colombo and Maathuis 2014; Peter
et al. 2000) (Supplementary Material) to study the relationships
A
B
Fig. 3. Illustration of the partial matrix correlation. (A) We will create artificial data such that X1 influences X2, which in turn influences X3. (B) Artificial data con-
sistent with the abovementioned causality, resulting in RV ðX1;X3jX2Þ  0
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between datasets. Briefly put, this algorithm starts out with a
fully connected graph, where each node corresponds to a dataset,
and removes the edge between two datasets X1 and X2 when
RV X1;X2jCð Þ  0 (i.e. when it is not significantly different from 0).
This step is repeated for increasingly larger sets of C, from C ¼ Ø
(no datasets) to C ¼ U n fX1;X2g (all datasets except X1 and X2),
until either the edge is removed or all possible sets have
been assessed. Finally, the PC algorithm attempts to, under
certain assumptions, determine the directionality of the edges
(Supplementary Material). However, for the pharmacogenomics
data, the algorithm was unable to infer the directionality of any
edge in the graph.
Using the approach outlined above, the PC algorithm essentially
summarizes the set of all 560 partial matrix correlations in a top-
ology. An important caveat of this approach is that it uses the ab-
sence of a significant association to determine the absence of a
relation between two datasets. As this may not always be true (there
may be such a relation, but we may not have enough objects to
detect it), we will also inspect the underlying (partial) matrix corre-
lations and their confidence intervals for the most important
hypotheses generated from the topology.
Figure 5 shows the topology resulting from the PC algorithm.
Gene expression takes up a strikingly central position in the graph,
being connected to all other data types. Using the underlying partial
correlations and their confidence intervals, we verify that gene ex-
pression acts as a mediator between the ‘upstream data’ (mutation,
CNA, methylation and cancer type) on the one hand and the drug
response data on the other hand: the partial matrix correlations be-
tween these datasets and the drug response drop to nearly zero when
correcting for gene expression (Fig. 6A).
Proteomics also takes up an interesting position in the graph.
The proteomics data shows a very strong relationship with gene ex-
pression (RV ¼ 0.76). Interestingly, using the underlying partial ma-
trix correlations, we see that this relationship fully contains the
information shared between the upstream data and proteomics:
RV Xi; proteomics j expressionð Þ  0, for each dataset Xi in the
upstream datasets (Fig. 6B). Finally, gene expression and proteomics
share information with drug response that is not present in the other
dataset: RV expression; drug response j proteomicsð Þ > 0 and RV
proteomics; drug response j expressionð Þ > 0 (Fig. 6C). Hence,
even though gene expression and proteomics share a large amount
of information, they both contain unique information with respect
to drug response.
Overall, we have shown here that our methodology can be used
to infer how different datasets are related to each other.
3.5 Identifying which variables predictive of drug
response are distinct to either gene expression or
proteomics
The topology that we have inferred suggests that for accurate predic-
tion of drug response we only need gene expression and proteomics.
Indeed, when we train Elastic Net models (Zou and Hastie 2005)
(Supplementary Material) to predict the drug response from either
all datasets (other than drug response) or from only gene expression
and proteomics, we found that they result in virtually identical pre-
dictive performance (Supplementary Fig. S2A).
We then asked which variables are both predictive of drug re-
sponse and distinct to either gene expression or proteomics. To an-
swer this question, we used TANDEM (Aben et al. 2016)
(Supplementary Material). Briefly, given a response vector y (e.g.
drug response of a single drug) and two datasets X1 and X2 (e.g.
gene expression and proteomics), TANDEM uses two stages of
Elastic Net regression to first identify all variables in X1 that are
associated with y, and then identify all variables in X2 that are asso-
ciated with y but whose information is not present in X1.
For each drug, we trained two TANDEM models:
• GEXunique: a model that uses proteomics in the first stage and
gene expression in the second stage, thereby identifying variables
with information that is unique to the gene expression data.
• PROTunique: the counterpart of GEXunique, with gene expression
in the first stage and proteomics in the second stage.
We found that GEXunique mostly uses proteomics data and
PROTunique mostly uses gene expression data, while both achieve
similar predictive performance (Supplementary Fig. S2B–D). This is
A B
Fig. 4. Artificial data experiment in which the RV coefficient (y-axis) is measured at different levels of similarity (a, x-axis), both with and without centering, for (A)
two continuous datasets and (B) two binary datasets
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of course not very surprising, as we have already seen using the RV
coefficient that a lot of information is shared between the gene ex-
pression and proteomics data.
For each drug and for both TANDEM models, we then deter-
mined variable importance scores (Supplementary Material) and
averaged these over drugs to identify variables that made the
largest overall contribution to the prediction of drug response. For
GEXunique, the most important gene expression variable was ABCB1
expression. ABCB1 is a protein in the cell membrane that pumps for-
eign substances (including drugs) out of the cell. As such, it is known
to be associated with resistance to a wide range of drugs (Garnett
et al. 2012). The proteomics data we considered here did not con-
tain ABCB1, hence it is not unexpected that this information is not
present in the proteomics data.
For PROTunique, the most important variable was MEK1 S217/
S221 phosphorylation (pMEK1). The phosphorylation of MEK1
indicates MAPK pathway activation and is hence associated to sensi-
tivity to MAPK pathway inhibitors, such as BRAF, MEK and ERK
inhibitors. As the proteomics data contains both phosphorylation
and protein abundance variables, we wondered whether one of these
classes might be enriched in the distinct proteomics—drug response
part. However, we found no significant difference between the vari-
able importance scores in the PROTunique models for these two
classes (P¼0.68, Mann–Whitney U Test) (Supplementary Fig. S2E).
Altogether, we have shown here that, informed by the topology
of the datasets we inferred with iTOP, we can identify which varia-
bles correspond to distinct gene expression—drug response and pro-
teomics—drug response relationships.
4 Discussion
In this work, we have introduced iTOP, a methodology to infer a
topology of relationships between datasets. To this end, we have
extended the RV coefficient for partial matrix correlations, allowing
one to identify how much information is shared between two data-
sets, but not present in other datasets. In addition, we have also
extended the partial RV coefficient for binary data, using the
Jaccard coefficient. We have tested both extensions using artificial
data and used them to infer a topology of the pharmacogenomics
data. Finally, we have zoomed in on part of the topology and have
identified variables predictive of drug response that are distinct to ei-
ther gene expression or proteomics using TANDEM.
A B C
Fig. 6. The (partial) matrix correlations for different RV ðX1;X2jX3Þ in the pharmacogenomics data. For each bar in the barplot, X1 and X2 are indicated by the black
blocks, and X3 is indicated by the red block. A (partial) matrix correlation was significant when P<0.01. The error bars indicate the 99% confidence interval. mut,
mutation; meth, methylation; expr, gene expression; prot, proteomics; drug, drug response
Fig. 5. Relationships between datasets in the pharmacogenomics data, as
determined using the PC algorithm run on the partial matrix correlations. An
edge indicates that two datasets share information that is not present in any
of the other datasets
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An important caveat of the PC algorithm used in our approach is
that the absence of a significant P-value does not necessarily mean
the absence of a relationship between two datasets: it can also mean
this relationship is present, but that we did not have enough power
to detect it. Of note, this also means that the inferred topology can
change as the number of objects increases, simply because this
enhances our ability to detect very small effects. For these reasons,
we suggest to not solely rely on P-values to determine the absence or
presence of these links. Instead, we suggest using the PC algorithm
as a tool to summarize the results from the numerous possible par-
tial matrix correlations into a topology, after which the hypotheses
generated from this topology should also be assessed by inspecting
the relevant (partial) matrix correlations and their confidence inter-
vals. These values will give an indication of both the strength of the
associations and how well we can estimate these, and may hence
suggest the inclusion of an association that is strong but uncertain,
or the exclusion of a certain—but weak—association.
We note that there are other options for binary similarity meas-
ures besides the Jaccard coefficient. For example, we have consid-
ered the phi coefficient, which is the Pearson correlation applied to
binary measurements (Yule 1912; Zegers 1986). The main benefit of
the phi coefficient is that it is a centered measure and hence kernel
centering of the resulting configuration is not required. A minor dis-
advantage of the phi coefficient is that it is not defined in cases
where objects consist of only zeroes or only ones. This can be easily
circumvented however, for example by defining phi(x, y) ¼ 0 in
these cases. The main disadvantage of the phi coefficient lies in its
definition of similarity: for the phi coefficient, both coinciding
zeroes and ones contribute towards similarity, whereas for the
Jaccard similarity only coinciding ones do. We believe objects are
similar when they share the same mutations (rather than the absence
of mutations) and hence prefer the Jaccard similarity here.
In future work, the RV coefficient could be further extended for
other types of data. For example, a matrix with ordinal data could
be converted into a configuration matrix using the Spearman rank
correlation or the rOZ coefficient similarity (Vegelius 1976; Zegers
1986). Additionally, other semi-positive definite kernels that de-
scribe the similarity between objects could be used as a configur-
ation matrix. For example, if we were to consider a dataset that is
represented as a graph (where each node corresponds to an object),
then a configuration matrix could be constructed using a graph dif-
fusion kernel (Imre Kondor and John 2002). Finally, as many multi-
omics data contain patient survival data, defining a configuration
matrix for survival data opens up interesting avenues for future re-
search. For each of these extensions, careful assessment of the need
of kernel centering will be required.
We believe that iTOP can be applied to a broad range of data,
beyond the pharmacogenomics data analyzed here. Essentially, for
all data in which the same objects have been characterized in mul-
tiple modalities, this methodology can be used to infer a topology of
relationships between the resulting datasets. Hence, as multi-omics
and phenotypic data is collected for increasingly more experiments,
we believe our methodology will be highly relevant and widely
applicable.
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